Skip To Main Content
Scott Patterson on Muck Rack

Scott Patterson

Santa Clarita
As seen in: Nature, MDPI, Postimees, Kitsap Sun, L'Opinion, Applied Radiology, Radiology Today Magazine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Scott

Contact Scott, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

WSJ: Trump annab ametisse astudes otsekohe fossiilkütuse toetamise käsu

|
By Scott Patterson
| Postimees Verified
Päevatoimetaja: Urho Meister urho.meister@postimees.ee Saada vihje The Wall Street Journal Tellijale Artikli sisu pärineb partnerväljaandest The Wall Street Journal. Donald Trump pidamas oma esimesel ametiajal kõnet naftatorni platvormi Double Eagle Energy Oil Rig juures Texases. Foto: CARLOS BARRIA / REUTERS Ameerika ametisse astuv president Donald Trump valmistab ette täitevkorraldusi fossiilkütuste toetamiseks ning eelkäija elektriautosurve lõpetamiseks.
Open in Who Shared Issue with article?

Clinical validation of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitis - Nature Medicine

|
By Hanna Pulaski, Stephen Harrison, Arun J Sanyal, Jonathan N. Glickman, Scott Patterson, Quentin M Anstee, Rohit Loomba, Vlad Ratziu, Andrew Beck, Adam Stanford-Moore
| Nature Verified
Abstract Metabolic dysfunction-associated steatohepatitis (MASH) is a major cause of liver-related morbidity and mortality, yet treatment options are limited. Manual scoring of liver biopsies, currently the gold standard for clinical trial enrollment and endpoint assessment, suffers from high reader variability.
Open in Who Shared Issue with article?

AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases - Nature Medicine

|
By Scott Patterson, Arun J Sanyal, Amaro Taylor-Weiner, S. Adam Stanford-Moore
| Nature Verified
Abstract Clinical trials in metabolic dysfunction-associated steatohepatitis (MASH, formerly known as nonalcoholic steatohepatitis) require histologic scoring for assessment of inclusion criteria and endpoints. However, variability in interpretation has impacted clinical trial outcomes. We developed an artificial intelligence-based measurement (AIM) tool for scoring MASH histology (AIM-MASH).
Open in Who Shared Issue with article?
See all 12 licensed articles (13 Total)